Navigation Links
Matrigel Matrix 100 mm Culture Dishes for Hepatocytes from BD Biosciences - Discovery Labware

ProductsMatrigel Matrix 100 mm Culture Dishes for Hepatocytes from BD Biosciences - Discovery Labware
Company BD Biosciences - Discovery Labware
Item Matrigel Matrix 100 mm Culture Dishes for Hepatocytes
Price 
Description BD BioCoat BD MatrigelTM Matrix 100 mm Culture Dishes for hepatocytes, tissue-culture treated polystyrene with a uniform application of MATRIGEL Matrix.
Info BD Biosciences - Discovery LabwareBD Biosciences - Discovery Labware
BD Biosciences - Discovery Labware
Two Oak Park Dr.
Bedford, MA 01730-9902
Customer Service: 800.343.2035
Fax Number: 800.743.6200
Web Site: http://www.bd.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. BD Biocoat Matrigel Matrix Thin Layer 35 mm Culture Dishes from BD Biosciences - Discovery Labware
2. BD BioCoat Matrigel Matrix 35 mm Culture Dishes from BD Biosciences - Discovery Labware
3. Nuclear Matrix Protein ELISA Kit from Calbiochem
4. Rabbit Anti-Matrix Metalloproteinase-2, Hinge Region Antibody, Unconjugated from Sigma-Aldrich
5. ECL Cell Attachment Matrix from Upstate
6. Human Laminin ELISA Kit, QuantiMatrix from Upstate
7. RayBio Human Matrix Metalloproteinase Antibody Array I & 1.1 Service from Raybiotech, Inc.
8. Sentrix Custom-96 Expression Array Matrix (1) from Illumina
9. Cultrex 3D Culture Matrix Laminin I from R&D Systems
10. Cultrex 3D Culture Matrix BME from R&D Systems
11. Cultrex 3D Culture Matrix Rat Collagen I from R&D Systems
Mouse monoclonal antibody raised against a partial recombinant SCARB2. NCBI Entrez Gene ID = SCARB2...
The F40 pump maintenance kit is used to service one F40 pump of a BioLogic DuoFlow workstation. It includes 2 piston seals, 4 check valves, seal removal tool, and 2 O-rings....
...
...
Biology Products:
(Date:9/2/2014)... With their long, spiky legs and their propensity for ... stuff of nightmares. And now research from North Carolina ... spread into homes across the eastern United States. , ... or pose any kind of threat to humans," says ... State and lead author of a paper about the ...
(Date:9/1/2014)... An increasing amount of research shows an association between ... sedentary lifestyle. Now, a new Cornell University study points ... programs might lead people to eat twice as much ... an action movie while snacking your mouth will see ... on the new article just published in the ...
(Date:9/1/2014)... after birth, every child in the U.S. undergoes a ... conditions, including sickle cell disease. Thousands of children born ... many suffer and die from the disease each year. ... to at least some of those deaths. , ... in the lab of George Whitesides, the Woodford L. ...
Breaking Biology News(10 mins):Researchers find Asian camel crickets now common in US homes 2Can action movies make you fat? 2Faster, cheaper tests for sickle cell 2Faster, cheaper tests for sickle cell 3
... Who is related to whom, who begat whom, how did ... reptiles. In 2011, his fieldwork in Sri Lanka studying ... identity of 60 known species of snakes. With Sri Lankan ... amphibians and reptiles, and Dushantha Kandambi, a local naturalist and ...
... Copenhagen, Denmark, Shenzhen, China. Tue., 12 March 2013 ... world,s largest genomics organization, will be working together aiming ... genomics and bioinformatics capabilities of both institutions. This partnership ... food security, energy and health. , Prof Richard Cogdell, ...
... to have an ambiguous, obscure or hidden meaning. In ... are hidden inside their genes. Two University of ... tiny clams, long believed to be members of the ... along the rocky shores of southern Australia for millions ...
Cached Biology News:Sri Lankan snake study reveals new species, rich biodiversity in island country 2BGI and TGAC join efforts to tackle global challenges in food security, energy and health 2Cryptic clams: U-M biologists find species hiding in plain view 2Cryptic clams: U-M biologists find species hiding in plain view 3
(Date:9/2/2014)...  Technology Applications International Corporation (the "Company" or "NUUU")(OTC ... Int,l, Inc. has signed an additional exclusive licensing agreement ... the Johnson Space Center in Houston ... Charles J. Scimeca , ... our latest, exclusive agreement with NASA. In addition to ...
(Date:9/2/2014)... Orexigen Therapeutics, Inc. (Nasdaq: OREX ... Office (PTO) has issued a patent related to NB32, ... NB32 is a fixed-dose combination of naltrexone sustained release ... 8,815,889 claims methods for treating insulin resistance using a ... 2024. If NB32 is approved for use in ...
(Date:9/2/2014)... 2014  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... candidates targeting specific pathogens that cause serious infections ... final preclinical toxicology study of SYN-004. Per U.S. ... study was required to move the Company,s lead ... devastating effects of Clostridium difficile (C. difficile), ...
(Date:9/2/2014)... , Sept. 2, 2014  Spherix Incorporated (SPEX) -- an intellectual ... of intellectual property, today announced that the United States ... the Company in the month of August that are ... The issued patents are: ... issued August 19, 2014; and , U.S.RE45,095 issued ...
Breaking Biology Technology:Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 2Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 3Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 2Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 3Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 4Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 2Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 3Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 4Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 5United States Patent & Trademark Office Issues Three New Standard Essential Patents to Spherix 2